机构风向标 | 九洲药业(603456)2025年二季度已披露前十大机构持股比例合计下跌1.62个百分点

Group 1 - The core viewpoint of the news is that Jiuzhou Pharmaceutical (603456.SH) has reported its half-year results for 2025, revealing significant institutional investor holdings and changes in share ownership [1] - As of August 5, 2025, a total of 14 institutional investors hold 378 million shares of Jiuzhou Pharmaceutical, accounting for 42.55% of the total share capital [1] - The top ten institutional investors collectively hold 42.53% of the shares, with a decrease of 1.62 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, there was an increase in holdings from one public fund, Huabao CSI Medical ETF, while one public fund, China Europe Medical Health Mixed Fund, saw a decrease of 0.49% [2] - Eight new public funds disclosed their holdings this period, including Jinguan Taifu Technology-Driven Mixed A and others [2] - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.23% compared to the previous quarter [2]